IT EN

On Focus

Author: Stefano La Rosa


News

Eva Maschietto assists Catalent in the environmental aspects of the acquisition of BMS plant in Anagni

Eva_Maschietto_MMLEX.jpg

Eva Maschietto, founding partner of MMLEX Maschietto Maggiore Besseghini has assisted Catalent in the environmental issues of the acquisition of Bristol-Myers Squibb plant in Anagni Italy, supporting the Freshfields Bruckhaus Deringer international team jointly with the Italian partner Fabrizio Arossa.

Catalent and BMS entered into an agreement, which is subject to certain conditions likely to be met by the end of 2019, for the sale of one of the flagship facilities involved in the development and production of synthetic and bio medicines, genetic therapies and over-the-counter drugs. Once the operation will be complete, Catalent will continue manufacturing the current portfolio of products for BMS in that facility.

04 LEGAL & QUICK CONTACT